Home » Topics » BioWorld Science

BioWorld Science
RSS

Chugai's metabolic drug R&D pipeline

Sep. 13, 1996

Rapamycin in anemia

Sep. 13, 1996

Warner-Lambert profiles ACAT inhibitors with hypocholesterolemic and antiatherosclerotic activity

Sep. 13, 1996

Vitamin D3 derivatives for osteoporosis

Sep. 13, 1996

New estrogen agonists and antagonists

Sep. 13, 1996

Novel treatment for bone loss

Sep. 13, 1996

U.S. approval for glaucoma medication

Sep. 13, 1996

Daiichi's anticancer drugs in development

Sep. 13, 1996

Chugai's anticancer R&D pipeline

Sep. 13, 1996

Expanded approval sought for Photofrin

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026